Globally, the number of people with multiple co-occurring diseases will increase
substantially over the coming decades, with important consequences for patients, carers …

Atherosclerosis is characterized by the development of intimal plaque, thrombosis, and
stenosis of the vessel lumen causing decreased blood flow and hypoxia precipitating …

Introduction The multiorgan impact of moderate to severe coronavirus infections in the post-
acute phase is still poorly understood. We aimed to evaluate the excess burden of …

The impact of COVID-19 on mortality from specific causes of death remains poorly
understood. This study analysed cause-of-death data provided by the World Health …

The direct and indirect impact of the COVID-19 pandemic on population-level mortality is of
concern to public health but challenging to quantify. Using data for 2011–2019, we applied …

Abstract Background Coronavirus disease 2019 (COVID-19) is associated with excess risk
of cardiovascular and thrombotic events in the early post-infection period and during …

Pneumonia is inflammation in the lungs, which is usually caused by an infection. The
symptoms of pneumonia can vary from mild to life-threatening, where severe illness is often …

Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

Three years after the start of the pandemic, approaches to the prevention and treatment of
acute Covid-19 have been established. However, post-acute sequelae of SARS-CoV-2 …